ARTICLE-7: Registration and notification of substances in articles [
go to this ARTICLE]
ARTICLE-13: General requirements for generation of information on intrinsic properties of substances [
go to this ARTICLE]
... 2. These
methods shall be regularly reviewed and improved with a
view to reducing
testing on
vertebrate animals and the
number of
animals involved. The
Commission, following
consultation with
relevant stakeholders, shall, as soon as possible, make a
proposal, if appropriate, to
amend the
Commission Regulation on
test methods adopted in
accordance with the
procedure referred to in
Article 133(4), and the
Annexes of this
Regulation, if
relevant, so as to replace, reduce or refine
animal testing.
Amendments to that
Commission Regulation shall be
adopted in
accordance with the
procedure specified in paragraph 3 and
amendments to the
Annexes of this
Regulation shall be
adopted in
accordance with the
procedure referred to in
Article 131. ...
... 2. These
methods shall be regularly reviewed and improved with a
view to reducing
testing on
vertebrate animals and the
number of
animals involved. The
Commission, following
consultation with
relevant stakeholders, shall, as soon as possible, make a
proposal, if appropriate, to
amend the
Commission Regulation on
test methods adopted in
accordance with the
procedure referred to in
Article 133(4), and the
Annexes of this
Regulation, if
relevant, so as to replace, reduce or refine
animal testing.
Amendments to that
Commission Regulation shall be
adopted in
accordance with the
procedure specified in paragraph 3 and
amendments to the
Annexes of this
Regulation shall be
adopted in
accordance with the
procedure referred to in
Article 131. ...
... 2. These
methods shall be regularly reviewed and improved with a
view to reducing
testing on
vertebrate animals and the
number of
animals involved. The
Commission, following
consultation with
relevant stakeholders, shall, as soon as possible, make a
proposal, if appropriate, to
amend the
Commission Regulation on
test methods adopted in
accordance with the
procedure referred to in
Article 133(4), and the
Annexes of this
Regulation, if
relevant, so as to replace, reduce or refine
animal testing.
Amendments to that
Commission Regulation shall be
adopted in
accordance with the
procedure specified in paragraph 3 and
amendments to the
Annexes of this
Regulation shall be
adopted in
accordance with the
procedure referred to in
Article 131. ...
ARTICLE-27: Sharing of existing data in the case of registered substances [
go to this ARTICLE]
ARTICLE-30: Sharing of data involving tests [
go to this ARTICLE]
ARTICLE-44: Criteria for substance evaluation [
go to this ARTICLE]
... 3. In
cases where two or more
Member States have expressed an
interest in evaluating the same
substance and they cannot
agree who should be the
competent authority, the
competent authority for the
purposes of
Articles 46,
47 and
48 shall be
determined in
accordance with the following
procedure. The
Agency shall refer the matter to the
Member State Committee, in
order to
agree which
authority shall be the
competent authority, taking into
account the
Member State in which the
manufacturer(s) or
importer(s) is located, the respective proportions of total
Community gross domestic product, the
number of
substances already being evaluated by a
Member State and the
expertise available. If, within 60
days of the
referral, the
Member State Committee reaches
unanimous agreement, the
Member States concerned shall
adopt substances for
evaluation accordingly. If the
Member State Committee fails to reach a
unanimous agreement, the
Agency shall submit the conflicting
opinions to the
Commission, which shall
decide which
authority shall be the
competent authority, in
accordance with the
procedure referred to in
Article 133(3), and the
Member States concerned shall
adopt substances for
evaluation accordingly. ...
... 3. In
cases where two or more
Member States have expressed an
interest in evaluating the same
substance and they cannot
agree who should be the
competent authority, the
competent authority for the
purposes of
Articles 46,
47 and
48 shall be
determined in
accordance with the following
procedure. The
Agency shall refer the matter to the
Member State Committee, in
order to
agree which
authority shall be the
competent authority, taking into
account the
Member State in which the
manufacturer(s) or
importer(s) is located, the respective proportions of total
Community gross domestic product, the
number of
substances already being evaluated by a
Member State and the
expertise available. If, within 60
days of the
referral, the
Member State Committee reaches
unanimous agreement, the
Member States concerned shall
adopt substances for
evaluation accordingly. If the
Member State Committee fails to reach a
unanimous agreement, the
Agency shall submit the conflicting
opinions to the
Commission, which shall
decide which
authority shall be the
competent authority, in
accordance with the
procedure referred to in
Article 133(3), and the
Member States concerned shall
adopt substances for
evaluation accordingly. ...
ARTICLE-47: Coherence with other activities [
go to this ARTICLE]
ARTICLE-62: Applications for authorisations [
go to this ARTICLE]
ARTICLE-64: Procedure for authorisation decisions [
go to this ARTICLE]
ARTICLE-71: Agency opinion: Committee for Socio-economic Analysis [
go to this ARTICLE]
ARTICLE-78: Powers of the Management Board [
go to this ARTICLE]
ARTICLE-82: Voting of the Management Board [
go to this ARTICLE]
ARTICLE-86: Establishment of the Forum [
go to this ARTICLE]
ARTICLE-87: Rapporteurs of Committees and use of experts [
go to this ARTICLE]
ARTICLE-89: Establishment of the Board of Appeal [
go to this ARTICLE]
ARTICLE-96: The budget of the Agency [
go to this ARTICLE]
ARTICLE-103: Staff rules and regulations [
go to this ARTICLE]
ARTICLE-110: Relations with relevant Community bodies [
go to this ARTICLE]
ARTICLE-115: Harmonisation of classification and labelling Committee for Risk Assessment shall adopt an opinion on the proposal, giving
parties [
go to this ARTICLE]
... 1.
Subject to paragraph 2,
Member States shall not
prohibit,
restrict or
impede the
manufacturing,
import, placing on the
market or use of a
substance, on its own, in a
preparation or in an
article, falling within the
scope of this
Regulation, which complies with this
Regulation and, where appropriate, with
Community acts adopted in
implementation of this
Regulation. ...
ARTICLE-132: Implementing legislation [
go to this ARTICLE]
ARTICLE-135: Transitional measures regarding notified substances [
go to this ARTICLE]
ARTICLE-136: Transitional measures regarding existing substances [
go to this ARTICLE]
ARTICLE-137: Transitional measures regarding restrictions [
go to this ARTICLE]